Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe-Reference-Cited by-同舟云学术

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

Published:2018-03-30 Issue:7 Volume:25 Page:811-817
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Cacoub P.¹²,Buggisch P.³,Carrión J. A.⁴,Cooke G. S.⁵,Zignego A. L.⁶,Beckerman R.⁷^ORCID,Younossi Z.⁸^ORCID

Affiliation:

1. AP-HP; Groupe Hospitalier Pitié-Salpêtrière; Department of Internal Medicine and Clinical Immunology; F-75013 Paris France

2. Sorbonne Université; UPMC Univ Paris 06; INSERM; Immunology-Immunopathology- Immunotherapy (I3); F-75005 Paris France

3. IFI Institut für Interdisziplinäre Medizin; Asklepios Klinik St. Georg; Hamburg Germany

4. Liver Section; Gastroenterology Department; Hospital del Mar; Universitat Autònoma de Barcelona; IMIM (Institut Hospital del Mar Medical Research Institute); Barcelona Spain

5. Division of Infectious diseases; Imperial College London; London UK

6. Interdepartmental Hepatology Center MaSVE; University of Florence; Florence Italy

7. Maple Health Group, LLC; New York NY USA

8. Betty and Guy Beatty Center for Integrated Research, Inova Health System; Falls Church VA USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12881/fullpdf

Reference64 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas;El Khoury;J Med Econ,2012

3. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C;Cacoub;Arthritis Rheum,1999

4. Value of treating all stages of chronic hepatitis C: a comprehensive review of clinical and economic evidence;Nuno Solinis;Infect Dis Therapy,2016

5. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden;Younossi;Gastroenterology,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals;PharmacoEconomics - Open;2023-12-15

2. Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain;PLOS ONE;2022-12-01

3. Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations;Journal Infectology;2022-07-13

4. Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C;PLOS ONE;2021-12-20

5. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis;Clinical Rheumatology;2021-08-19